Characterization of a new rat model of heritable PAH

Hautefort Aurelie (Le Plessis Robinson, France), Hautefort Aurelie, Catherine Rucker Martin, Veronique Capuano, Florence Lecerf, Peter Dorfmüller, Barbara Girerd, David Montani, Marc Humbert, Fabrice Antigny, Frederic Perros

Source: International Congress 2016 – Pulmonary hypertension: novel insights
Session: Pulmonary hypertension: novel insights
Session type: Oral Presentation
Number: 3007
Disease area: Pulmonary vascular diseases

Congress or journal article abstractSlide presentation

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Hautefort Aurelie (Le Plessis Robinson, France), Hautefort Aurelie, Catherine Rucker Martin, Veronique Capuano, Florence Lecerf, Peter Dorfmüller, Barbara Girerd, David Montani, Marc Humbert, Fabrice Antigny, Frederic Perros. Characterization of a new rat model of heritable PAH. Eur Respir J 2016; 48: Suppl. 60, 3007

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Temporal hemodynamic and histological changes in a rat model of SUGEN-induced PAH
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016


Role of the TrkA receptor in experimental severe pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Effect of diminazene on monocrotalin-induced pulmonary hypertension rat model
Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease
Year: 2015

Role of survivin in experimental models of pulmonary arterial hypertension
Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside
Year: 2016

Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Characterisation of an experimental mouse model of exposure to nanoparticles. Relevance to human sarcoidosis
Source: International Congress 2015 – Sarcoidosis: clinical
Year: 2015

Caspase inhibition stabilizes progressive vascular remodeling in established pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


Intact serotonin signaling is not required for the development of severe angioproliferative pulmonary hypertension in rats
Source: International Congress 2014 – Pathobiology of pulmonary hypertension
Year: 2014

Mepenzolate bromide displays beneficial effects in a mouse model of chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models in respiratory drug development
Year: 2014


A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease
Source: International Congress 2014 – Animal models: asthma, COPD and beyond
Year: 2014

Role of microRNA 17/92 cluster and microRNA 21 in the pathogenesis of pulmonary hypertension – Novel therapeutic targets
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013

AAV-Tgfb1 vs. bleomycin: Analysis of gene expression profiles in two models of pulmonary fibrosis
Source: International Congress 2014 – Novel approaches in transcriptomics and epigenomics in inflammatory lung diseases and lung cancer
Year: 2014

Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments
Year: 2013


A new method for parameter identification in a lumped model of pulmonary circulation
Source: International Congress 2015 – Pulmonary hypertension: the right ventricle and its load
Year: 2015


Expression and function of aquaporin 1 in hypoxia-induced pulmonary hypertension
Source: International Congress 2015 – Pulmonary hypertension: promising small molecules
Year: 2015

Animal models of pulmonary emphysema: a stereologist's perspective
Source: Eur Respir Rev 2006; 15: 136-147
Year: 2006



Prolonged activity of inhaled treprostinil prodrug nanoparticles in a rat model of pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs
Year: 2014